Algene Holding SE has reported positive interim results from a scientific study conducted with the Chair of Aquatic Systems Biology at the Technical University of Munich (TUM), led by Prof. Dr. Jurgen Geist. The study examines the use of Algene's high-purity Spirulina microalgae as a feed component in industrial shrimp farming. After only a few days of testing, statistically significant differences in consumption rates emerged between a control group fed without Spirulina and a group receiving feed enriched with 100% Spirulina. These interim findings suggest the Algene product positively influences shrimp growth, and if confirmed, could deliver significant economic advantages for aquaculture producers.
The implications extend beyond feed performance. The global aquaculture market is projected to grow from USD 653.8 billion in 2026 to USD 1.2 trillion by 2034, a compound annual growth rate of 7.3%. By demonstrating that Spirulina can drive higher consumption rates, Algene is positioning itself within a dynamically expanding sector that encompasses the breeding, rearing, and harvesting of fish, shellfish, and aquatic plants. Final study results, expected in November, would serve as a "proof of concept" for Algene's approach and could accelerate its entry into the aquaculture market.
Algene is currently in advanced discussions with potential customers in the sector. CEO Kai Maximilian Keller stated that the interim results are "extremely promising" and indicate the potential for significant positive economic impacts within the aquaculture industry. He noted that TUM provides a strong academic partner for tapping into new growth markets, with the study's conclusion set to provide a major boost. The advanced customer discussions further demonstrate strong demand for algae-based products.
For investors, the interim data offers early validation of Algene's strategy to diversify its Spirulina applications beyond existing markets. The aquaculture sector's sheer scale and growth trajectory make even modest gains in feed efficiency economically meaningful for producers, and a successful proof of concept could open a substantial new revenue stream for the company. The study's final results in November will be a key milestone to watch, as they will determine whether the interim findings hold and whether Algene can convert academic validation into commercial contracts. The original release is available via www.newmediawire.com.
